A decade of advances in multiple myeloma and unanswered questions
Trial results of idelalisib with bendamustine and rituximab in CLL
Insights from the RAY trial: treating relapsed mantle cell lymphoma patients
Ibrutinib updates from ASH 2016
What does the CLL forum data tell us?